Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31
Phase 43

Trial Status

Completed5
Other1

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT05058976Phase 4Active Not Recruiting
Romosozumab Use to Build Skeletal Integrity
OsteoporosisOsteoporosis FractureOsteoporosis, Postmenopausal
PrincipalinvestigatorStart date: 2021-09-15
NCT02753283Phase 4Completed
Preventing Osteoporosis Using Denosumab
OsteoporosisOsteoporosis, PostmenopausalOsteoporotic Fractures
PrincipalinvestigatorStart date: 2016-06-01
NCT02589600Phase 4Completed
Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)
Osteoporosis, PostmenopausalOsteoporotic Fractures
PrincipalinvestigatorStart date: 2016-01-01
NCT00558012Not ApplicableCompleted
Zoledronic Acid for Osteoporosis in the Elderly
Bone LossFragility FracturesOsteoporosis
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT05058976Phase 4PrincipalInvestigator

Romosozumab Use to Build Skeletal Integrity

OsteoporosisOsteoporosis FractureOsteoporosis, Postmenopausal
Active Not Recruiting
NCT02753283Phase 4PrincipalInvestigator

Preventing Osteoporosis Using Denosumab

OsteoporosisOsteoporosis, PostmenopausalOsteoporotic Fractures
Completed
NCT02589600Phase 4PrincipalInvestigator

Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)

Osteoporosis, PostmenopausalOsteoporotic Fractures
Completed
NCT00118508Not ApplicablePrincipalInvestigator

The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)

Osteoporosis
Completed
NCT00177619Phase 3PrincipalInvestigator

Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)

Prostatic Neoplasms
Completed
NCT00558012Not ApplicablePrincipalInvestigator

Zoledronic Acid for Osteoporosis in the Elderly

Bone LossFragility FracturesOsteoporosis
Completed

All 6 trials loaded